Saturday, September 27th, 2014 Cancer Survivors Day
Rush University Medical Center is proud to invite you to a
“Celebration of Life,” our annual Cancer Survivors’ Day Celebration.
Please join us on Saturday, September 27th from noon to 4pm at Rush University Medical Center, 1725 W. Harrison St., Searle Conference Center, Room 500, Chicago
Complimentary food & refreshments
Music, Activities, informational booths, special guest speakers
And so much more………
MEET OUR TEAM
Antonio M. Jimenez, MD, is an Assistant
Professor of Internal Medicine in the Section of Stem Cell Transplantation and
Cell Therapy in the Division of Hematology-Oncology-Cell Therapy at Rush
University Medical Center. Dr. Jimenez
graduated from Universidad Del Zulia Medical School in Maracaibo,
Venezuela. He completed his Internal Medicine
residency and Hematology-Oncology fellowship at Rush University Medical Center
in Chicago. While in Chicago, Dr.
Jimenez received a Master of Science degree in Clinical Research from Rush
Medical College. Dr. Jimenez then
completed a fellowship in Stem Cell Transplantation and Cellular Therapy at The
University of Texas M.D. Anderson Cancer Center in Houston, TX. His clinical interests include bone marrow
and stem cell transplantation, bone marrow harvest, graft-versus-host disease,
acute and chronic leukemias, myelodysplastic syndromes and myeloproliferative
neoplasms. Dr. Jimenez conducts research
primarily in hematopoietic stem cell transplantation, and has published his
findings in several medical journals.
Dr. Jimenez is fluent in Spanish.
John J. Maciejewski, MD, PhD, is currently the Interim
Director of the Section of Bone Marrow Transplant and Cell Therapy at Rush, as
well as the Clinical Program Director for Foundation for the Accreditation of
Cellular Therapy (FACT). He staffs the outpatient bone marrow transplant (BMT)
clinics as well as the inpatient bone marrow transplant rounds. His
primary focus in stem cell transplantation has been in the fields of acute
leukemia and multiple myeloma; he participates in both the Leukemia
Comprehensive Care Clinic and the Multiple Myeloma Comprehensive Care Clinic.
Dr. Maciejewski follows patients from diagnosis, through initial induction
therapy, then throughout the stem cell transplantation process, and beyond. He
also treats patients who suffer from graft-versus-host disease (GVHD), as well
as patients who suffer from disease relapse after allogeneic stem cell
transplantation. He is planning the inception of a BMT clinic devoted to the
treatment of patients who have relapsed following allogeneic stem cell
He is the principal investigator at Rush for several clinical trials targeting
bone marrow transplant recipients and multiple myeloma patients. One of these
clinical trials (BMT CTN 0702) is a study of single autologous transplant with
or without consolidation therapy versus tandem autologous transplant with
lenalidomide maintenance for multiple myeloma.
In addition, he has pledged to serve as a first-responder for the Midwestern
United States in the Radiation Injury Treatment Network (RITN), which provides
comprehensive evaluation and treatment for mass casualties with marrow toxic
injuries from ionizing radiation exposure or other hazardous material.
Dr. Maciejewski holds memberships in the American Society for Blood and Marrow
Transplantation, the American Society of Hematology, the American Society of
Clinical Oncology, and in the Scientific Research Society, Sigma Xi.
Nathan, MD, is the Associate Director of the
Section of Bone Marrow Transplant and Cell Therapy at Rush University Medical
Center (RUMC) and an Assistant Professor of Medicine in the Department of
Internal Medicine. She received her MD from BJ Medical College, University of
Pune, India. She completed her residency in Internal Medicine as well as
fellowship in Hematology and Oncology at the John H. Stroger, Jr. Hospital of
Cook County (Cook County Hospital) in Chicago where she also served as Chief Resident
and Chief Fellow. During her senior year
of fellowship, Dr. Nathan pursued subspecialty training in bone marrow transplantation and hematologic
malignancies, under Dr. Henry Fung at Rush University Medical Center.
Dr. Nathan is triple-board certified in Internal
Medicine, Hematology and Medical Oncology.
She holds memberships in the American Society of Hematology, the
American Society of Clinical Oncology, the American Society for Blood and
Marrow Transplantation and the American College of Physicians. Dr. Nathan's main area of clinical interest
is use of allogeneic stem cell transplantation in various hematologic
malignancies with a focus on its use in lympho-proliferative disorders such as
lymphoma and chronic lymphocytic leukemia. She has helped establish the
haplo-identical (half-matched donor) transplant program at RUMC and has lead the use of donor lymphocyte
infusion as a modality to treat post-transplant relapse. Her active research
endeavors are focused on the use of transplantation in the management of
lymphoma and evaluation of the use of novel targeted agents in the
post-transplant setting. Dr. Nathan is
fluent in English, Hindi, Malayalam and Marathi and is conversant in Swedish.
Rush's transplant program is fully accredited for:
- Allogeneic and autologous marrow
- Peripheral blood progenitor cell transplantation, including cell collection and laboratory processing
For more information on BMT, click here
Accreditation and Recognition